<DOC>
	<DOCNO>NCT01410942</DOCNO>
	<brief_summary>The goal clinical research study learn effect different combination exercise , supportive counseling , methylphenidate/placebo treatment fatigue patient prostate cancer . The safety treatment combination also study . Methylphenidate stimulant design increase activity central nervous system . A placebo drug . It look like study drug design treat symptom , disease illness . It design compare study drug learn study drug real effect . The exercise study design help improve physical fitness energy level . Supportive counseling design help control symptom , fatigue , anxiety , depression , pain , and/or sleep disorder .</brief_summary>
	<brief_title>Multimodal Therapy Treatment Fatigue Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy</brief_title>
	<detailed_description>If find eligible agree take part study : - You complete baseline exercise assessment last 30-45 minute include follow : - A sit-to-stand test . You sit chair arm across chest . Then time stand sit 5 time quickly possible . - A hand-grip strength test . You grip device hand hard . - A 6-minute walk test . You time walk 100-foot loop . You walk 50 foot turn walk back begin . You walk speed feel comfortable many time 6 minute . - You give belt ( accelerometer ) require wear first week treatment . The accelerometer measure physical activity . Study Groups : You randomly assign ( roll dice ) 1 8 study group . You equal chance assign group . You 50 % chance receive placebo . The exercise skill learn counsel different study group . The study staff talk assign exercise skill . You assign 1 2 type exercise group . One group resistance exercise walk , group stretch . You assign 1 2 type counsel group . One group receive education relaxation symptom . The group receive standard supportive counseling . Neither medical study staff know group . Only study staff work exercise counsel know group . If need safety , medical staff able find group . Study Drug/Placebo Administration : You take methylphenidate/placebo capsule mouth water , 2 time day . You must take dos 3 PM wait least 2 hour dos . Study Visits : For study visits/calls , ask drug may take side effect may . At home study , continue practice exercise exercise session skill counsel session . On Day 1 , do Screening : - Your medical history record . - You physical exam , include measurement vital sign . - You complete 5 questionnaire , last 30 minute . The questionnaire ask : - Your emotional physical well - Your level fatigue - Any anxiety and/or depression may - Any symptom may On Day 8 ( +/- 3 day ) : - You meet counselor . You ask discuss thought feeling different topic related well-being . The counseling session last 45 minute . - You meet exercise trainer . The exercise trainer teach exercise give write instruction home . The exercise meeting last 30-45 minute . - You ask complete questionnaire ask symptom and/or side effect may . This take 10 minute . On Days 15 29 ( +/- 3 day ) : - You exercise ask exercise go either person later phone . This last 30 minute . - You counsel session counselor phone . This last 45 minute . - You complete 5 questionnaire . On Days 22 36 ( +/- 3 day ) exercise trainer counselor call . These call last 30-45 minute . On Day 43 ( +/- 3 day ) exercise trainer counselor call . These call last 30-45 minute . -You complete questionnaire ask symptom and/or side effect may . This take 10 minute . On Day 50 ( +/- 3 day ) exercise trainer counselor call uncompleted session . These call last 30-45 minute . -You give accelerometer require wear last week treatment . On Day 57 ( +/- 10 day ) return clinic : - You physical exam , include measurement vital sign . - You complete sit-to-stand test . - You complete hand-grip strength test . - You complete 6-minute walk test . - You complete 5 questionnaire . Length Study Participation : You may continue take study drug/placebo 57 day ( +/- 10 day ) . You longer able take study drug/placebo disease get bad , intolerable side effect occur , unable follow study direction , complete enough treatment combination plan . Your participation study complete follow-up visit . Follow-Up Visit : About 3 month last dose study drug/placebo , return clinic follow-up visit : - You ask side effect may . - You physical exam , include measurement vital sign . - Your performance status record . - You complete sit-to-stand test . - You complete hand-grip strength test . - You complete 6-minute walk test . - You ask complete 5 questionnaire . This investigational study . Methylphenidate tablet FDA approve commercially available treatment attention deficit disorder ( ADD ) . The methylphenidate capsule make methylphenidate tablet especially study approved FDA . The combination methylphenidate , exercise , counsel consider investigational . Up 175 patient take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>1 . Have diagnosis prostate cancer schedule receive radiotherapy androgen deprivation therapy 2 . Rate fatigue least 1 high scale 010 . 3 . Describe fatigue present every day day minimum 2 week . 4 . Have clinical evidence cognitive failure evidence Memorial Delirium Assessment Scale ( MDAS ) score &lt; /=13 baseline . 5 . Be age 18 year old . 6 . Be willing engage followup telephone call research nurse/coordinator . 7 . Be willing participate exercise Cognitive Behavioral Therapy ( CBT ) . 8 . Have telephone access contact research nurse/coordinator . 9 . Have hemoglobin level &gt; /=10 g/dL within 2 week enrollment . 10 . Be able understand description study give write informed consent . 11 . Have Zubrod performance status 0 2 . 1 . Have major contraindication MP ( e.g. , allergy/hypersensitivity study medication constituent ) , exercise ( e.g. , cardiac disease ) , cognitive behavioral therapy ( e.g. , schizophrenia ) , condition make adherence difficult determine attend physician . 2 . Be currently take MP take within previous 10 day . 3 . Are regularly engage moderate vigorousintensity exercise least 150 minute per week . 4 . Regularly use cognitive behavioral therapy last 6 week . 5 . Be unable complete baseline assessment form understand recommendation participation study . 6 . Need monoamine oxidase inhibitor , tricyclic antidepressant , clonidine . 7 . Have glaucoma . 8 . Have history severe cardiac disease ( New York Heart Association functional class III IV ) . 9 . Have tachycardia and/or uncontrolled hypertension 10 . Be currently receive anticoagulant , anticonvulsant ( phenobarbital , diphenylhydantoin , primidone ) , phenylbutazone , and/or tricyclic drug ( imipramine , clomipramine , desipramine ) . 11 . History uncontrolled hypothyroidism evidence thyroid test ( TSH ) within last month , hypercalcemia hyperglycemia ( within last 15 day ) . 12 . Unable speak understand English 13 . Any medical psychological condition reason , accord investigator 's judgment , make patient unsuitable participation study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Prostate Cancer</keyword>
	<keyword>Multimodal Therapy</keyword>
	<keyword>MMT</keyword>
	<keyword>Fatigue</keyword>
	<keyword>Cognitive Behavioral Therapy</keyword>
	<keyword>CBT</keyword>
	<keyword>Radiation therapy</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>RT</keyword>
	<keyword>Functional Assessment Chronic Illness Therapy - Fatigue</keyword>
	<keyword>FACIT-F</keyword>
	<keyword>Androgen deprivation therapy</keyword>
	<keyword>Methylphenidate</keyword>
	<keyword>Methylphenidate Hydrochloride</keyword>
	<keyword>Ritalin</keyword>
	<keyword>Concerta</keyword>
	<keyword>Placebo</keyword>
	<keyword>Sugar Pill</keyword>
</DOC>